BRADLEY TODD: Open Payments
NPI 1134665011 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 12 payments from 10 companies in 2025. Trend: 2023 $337 · 2024 $276 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Novo Nordisk Inc | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Organon LLC | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: FANAPT, BEXSERO, Ozempic, TRELEGY ELLIPTA, GEMTESA, NEXPLANON, QULIPTA, FREESTYLE LIBRE 3.
Industry payments across MI — which companies pay providers there.
